David Harding

David Harding is a seasoned executive with extensive experience in the healthcare and diagnostics sectors. Currently serving as SVP of Multi-Cancer Early Detection at Exact Sciences, David focuses on the diligence and integration of acquired businesses and market access for product lines in the U.S. Previously, as SVP of Strategy and Business Development at T2 Biosystems, David led global marketing and sales efforts, achieving significant revenue growth. David held several leadership roles at Hologic, where oversight included the management of substantial P&L operations and driving revenue growth across various product lines. Throughout a career that includes positions at Cytyc Corporation and McKinsey & Company, David has demonstrated expertise in corporate strategy, market expansion, and operational improvement. David earned an MBA in Marketing and Finance from The Wharton School and a Bachelor of Science in Aerospace Engineering from the University of Southern California.